Correlation Between Uniteds and Big Pharma
Can any of the company-specific risk be diversified away by investing in both Uniteds and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniteds and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uniteds Limited and Big Pharma Split, you can compare the effects of market volatilities on Uniteds and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniteds with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniteds and Big Pharma.
Diversification Opportunities for Uniteds and Big Pharma
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Uniteds and Big is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Uniteds Limited and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Uniteds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniteds Limited are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Uniteds i.e., Uniteds and Big Pharma go up and down completely randomly.
Pair Corralation between Uniteds and Big Pharma
Assuming the 90 days trading horizon Uniteds Limited is expected to generate 0.8 times more return on investment than Big Pharma. However, Uniteds Limited is 1.25 times less risky than Big Pharma. It trades about 0.09 of its potential returns per unit of risk. Big Pharma Split is currently generating about 0.02 per unit of risk. If you would invest 10,273 in Uniteds Limited on September 12, 2024 and sell it today you would earn a total of 3,078 from holding Uniteds Limited or generate 29.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Uniteds Limited vs. Big Pharma Split
Performance |
| Timeline |
| Uniteds Limited |
| Big Pharma Split |
Uniteds and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Uniteds and Big Pharma
The main advantage of trading using opposite Uniteds and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniteds position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.| Uniteds vs. Economic Investment Trust | Uniteds vs. Canadian General Investments | Uniteds vs. E L Financial Corp | Uniteds vs. Clairvest Group |
| Big Pharma vs. Sustainable Power Infrastructure | Big Pharma vs. Global Dividend Growth | Big Pharma vs. Brompton Lifeco Split | Big Pharma vs. Prime Dividend Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |